RU2011146144A - Новые стабильные кристаллы моногидрохлорида 1-(2'-дезокси-бета-d-арабинофуранозил)цитозина - Google Patents
Новые стабильные кристаллы моногидрохлорида 1-(2'-дезокси-бета-d-арабинофуранозил)цитозина Download PDFInfo
- Publication number
- RU2011146144A RU2011146144A RU2011146144/02A RU2011146144A RU2011146144A RU 2011146144 A RU2011146144 A RU 2011146144A RU 2011146144/02 A RU2011146144/02 A RU 2011146144/02A RU 2011146144 A RU2011146144 A RU 2011146144A RU 2011146144 A RU2011146144 A RU 2011146144A
- Authority
- RU
- Russia
- Prior art keywords
- arabinofuranosyl
- deoxy
- crystals
- cytozine
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
1. Кристаллы моногидрохлорида 1-(2′-циано-2′-дезокси-β-D-арабинофуранозил)цитозина, имеющие характеристические пики при 13,7°, 15,7°, 16,0°, 18,6°, 20,3° и 22,7° в виде углов дифракции (2θ±0,1°), измеренных при порошковом рентгеноструктурном анализе, и имеющие температуру плавления 192-197°С.2. Кристаллы моногидрохлорида 1-(2′-циано-2′-дезокси-β-D-арабинофуранозил)цитозина, имеющие характеристические пики при 6,4°; 12,3°; 17,3° и 21,7° в виде углов дифракции (2θ±0,1°), измеренных при порошковом рентгеноструктурном анализе, и имеющие температуру плавления 192-197°С.3. Фармацевтическая композиция, содержащая кристаллы по п.1 или 2.4. Противоопухолевое средство, содержащее кристаллы по п.1 или 2.
Claims (4)
1. Кристаллы моногидрохлорида 1-(2′-циано-2′-дезокси-β-D-арабинофуранозил)цитозина, имеющие характеристические пики при 13,7°, 15,7°, 16,0°, 18,6°, 20,3° и 22,7° в виде углов дифракции (2θ±0,1°), измеренных при порошковом рентгеноструктурном анализе, и имеющие температуру плавления 192-197°С.
2. Кристаллы моногидрохлорида 1-(2′-циано-2′-дезокси-β-D-арабинофуранозил)цитозина, имеющие характеристические пики при 6,4°; 12,3°; 17,3° и 21,7° в виде углов дифракции (2θ±0,1°), измеренных при порошковом рентгеноструктурном анализе, и имеющие температуру плавления 192-197°С.
3. Фармацевтическая композиция, содержащая кристаллы по п.1 или 2.
4. Противоопухолевое средство, содержащее кристаллы по п.1 или 2.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009118726 | 2009-05-15 | ||
| JP2009-118726 | 2009-05-15 | ||
| PCT/JP2010/003261 WO2010131475A1 (ja) | 2009-05-15 | 2010-05-14 | １－（２'－シアノ－２'－デオキシ－β－Ｄ－アラビノフラノシル）シトシン・一塩酸塩の新規安定形結晶 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2011146144A true RU2011146144A (ru) | 2013-06-20 |
| RU2538593C2 RU2538593C2 (ru) | 2015-01-10 |
Family
ID=43084859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011146144/04A RU2538593C2 (ru) | 2009-05-15 | 2010-05-14 | НОВЫЕ СТАБИЛЬНЫЕ КРИСТАЛЛЫ МОНОГИДРОХЛОРИДА 1-(2-β-D-АРАБИНОФУРАНОЗИЛ)ЦИТОЗИНА |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8377905B2 (ru) |
| EP (1) | EP2431376B2 (ru) |
| JP (2) | JP5801715B2 (ru) |
| KR (1) | KR101414888B1 (ru) |
| CN (1) | CN102414216B (ru) |
| DK (1) | DK2431376T4 (ru) |
| ES (1) | ES2426025T5 (ru) |
| FI (1) | FI2431376T4 (ru) |
| HR (1) | HRP20131090T4 (ru) |
| PL (1) | PL2431376T3 (ru) |
| PT (1) | PT2431376E (ru) |
| RU (1) | RU2538593C2 (ru) |
| WO (1) | WO2010131475A1 (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0625283D0 (en) | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
| WO2013146833A1 (ja) * | 2012-03-28 | 2013-10-03 | 富士フイルム株式会社 | １－（２－デオキシ－２－フルオロ－４－チオ－β－Ｄ－アラビノフラノシル）シトシンの塩 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2559917B2 (ja) | 1990-06-15 | 1996-12-04 | 三共株式会社 | ピリミジンヌクレオシド誘導体 |
| CA2079413C (en) * | 1991-09-30 | 2003-09-09 | Masakatsu Kaneko | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use |
| US5637688A (en) * | 1994-12-13 | 1997-06-10 | Eli Lilly And Company | Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride |
| GB0526419D0 (en) * | 2005-12-23 | 2006-02-08 | Cyclacel Ltd | Formulation |
-
2010
- 2010-05-14 RU RU2011146144/04A patent/RU2538593C2/ru active
- 2010-05-14 EP EP10774734.7A patent/EP2431376B2/en active Active
- 2010-05-14 KR KR1020117027019A patent/KR101414888B1/ko active IP Right Grant
- 2010-05-14 PT PT107747347T patent/PT2431376E/pt unknown
- 2010-05-14 ES ES10774734T patent/ES2426025T5/es active Active
- 2010-05-14 PL PL10774734T patent/PL2431376T3/pl unknown
- 2010-05-14 DK DK10774734.7T patent/DK2431376T4/da active
- 2010-05-14 CN CN201080017920.4A patent/CN102414216B/zh active Active
- 2010-05-14 FI FIEP10774734.7T patent/FI2431376T4/fi active
- 2010-05-14 JP JP2011513251A patent/JP5801715B2/ja active Active
- 2010-05-14 US US13/264,111 patent/US8377905B2/en active Active
- 2010-05-14 WO PCT/JP2010/003261 patent/WO2010131475A1/ja active Application Filing
-
2013
- 2013-11-14 HR HRP20131090TT patent/HRP20131090T4/hr unknown
-
2015
- 2015-06-10 JP JP2015117232A patent/JP6307045B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102414216B (zh) | 2015-01-21 |
| KR101414888B1 (ko) | 2014-07-03 |
| ES2426025T3 (es) | 2013-10-18 |
| HRP20131090T4 (hr) | 2024-03-15 |
| PT2431376E (pt) | 2013-09-17 |
| JP5801715B2 (ja) | 2015-10-28 |
| HRP20131090T1 (hr) | 2013-12-20 |
| EP2431376B1 (en) | 2013-08-14 |
| US20120029182A1 (en) | 2012-02-02 |
| ES2426025T5 (es) | 2024-06-13 |
| EP2431376B2 (en) | 2024-02-07 |
| CN102414216A (zh) | 2012-04-11 |
| US8377905B2 (en) | 2013-02-19 |
| JP2015157867A (ja) | 2015-09-03 |
| FI2431376T4 (fi) | 2024-03-13 |
| EP2431376A4 (en) | 2012-08-01 |
| WO2010131475A1 (ja) | 2010-11-18 |
| JPWO2010131475A1 (ja) | 2012-11-01 |
| JP6307045B2 (ja) | 2018-04-04 |
| DK2431376T3 (da) | 2013-09-02 |
| RU2538593C2 (ru) | 2015-01-10 |
| KR20120022940A (ko) | 2012-03-12 |
| PL2431376T3 (pl) | 2014-01-31 |
| DK2431376T4 (da) | 2024-02-26 |
| EP2431376A1 (en) | 2012-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY186531A (en) | Crystals | |
| MX343837B (es) | Derivados de 2 - (1,2,3 -triazol - 2 - il) benzamida y 3 - (1,2,3 - triazol - 2 - il) picolinamida. | |
| MX2010003001A (es) | Derivados de quinolina como antagonistas del receptor de la 5-hidroxitriptamina 5a. | |
| RS52375B (en) | STABLE CRYSTALS OF 4-OXOCHINOLINE COMPOUND | |
| UY31419A1 (es) | Nueva forma cristalina vi de la agomelatina, su procedimiento de preparacion y las composiciones farmacéuticas que la contienen | |
| WO2009016460A3 (en) | Pyrazole compounds and their use as raf inhibitors | |
| MX2010003155A (es) | Derivados de ciclopropil aril amida y uso de los mismos. | |
| MX2009002306A (es) | Nuevos inhibidores de mdm2 de molecula pequeña y sus usos. | |
| MX2009009690A (es) | Derivados de tiazolidina como antagonistas del receptor de orexina. | |
| ME01488B (me) | Derivati oksadiazola i njihovo korišćenje kao potencijatora metabotropnih glutamatnih receptora-842 | |
| MY153985A (en) | Aminotriazole derivatives as alx agonists | |
| MY151986A (en) | Adamantyl diamide derivatives and uses of same | |
| ATE493386T1 (de) | Trans-3-aza-bicyclo-ä3.1.0ü-hexan-derivate | |
| TW200740814A (en) | Compounds | |
| MX2010001338A (es) | Derivados de pirimidina y piridina y su uso y composiciones farmaceuticas. | |
| MX2010001575A (es) | Derivados de 1,2-diamido-etileno como antagonistas de orexina. | |
| MX2007003913A (es) | Alquil-piridinas como inhibidores de 11 beta para diabetes. | |
| MY143557A (en) | Beta-crystalline form of perindopril arginine salt, process for its preparation, and pharmaceutical compositions containing it | |
| NO20085317L (no) | Imidazoazepinonforbindelser | |
| TW200619206A (en) | Chemokine-binding heterocyclic compound salts, and methods of use thereof | |
| RS53521B1 (en) | PREPARATION AND THERAPY APPLICATIONS (2S, 3R) -N-2 - ((3-pyridinyl) methyl) -1-AZABICYCLO [2.2.2] OCT-3-IL) -3,5-DIFLUOROBENZAMIDE | |
| HRP20110641T1 (en) | Crystalline modification of fipronil | |
| RS53910B1 (en) | METHYLPARABEN CO-CRYSTAL FORM "A" [4- (3-FLUORO-5-TRIFLUOROMETHYL-PYRIDIN-2-IL) -PIPERAZIN-I-IL] - [5-METHANSULFONYL-2 - ((S) -2,2,2- TRIFLUORO-1-METHYL-ETHOXY) -Phenyl] -METHANONE | |
| MX2010001705A (es) | Co-cristales de pirimetanilo y ditianona. | |
| UA89905C2 (ru) | α КРИСТАЛЛИЧЕСКАЯ ФОРМА АРГИНИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, КОТОРАЯ ЕЕ СОДЕРЖИТ |